about
Immunological aspects in chronic lymphocytic leukemia (CLL) developmentBLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteinsCD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cellsCD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.Recent progress in the understanding of B-cell functions in autoimmunity.Natural IgM prevents autoimmunity by enforcing B cell central tolerance inductionAnalysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus.Identification and characterization of circulating human transitional B cells.Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosusRegulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance.Regulation of plasma-cell development.Cellular and genetic mechanisms of self tolerance and autoimmunity.Loss of the proapoptotic protein, Bim, breaks B cell anergyPositive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell developmentGenetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity.Characteristics of natural antibody-secreting cells.Central and peripheral RAG protein re-expression: underestimate mechanisms of tolerance?Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupusThe CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.CD5 sweetens lymphocyte responsesCD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytesA conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells.Modulation of peripheral B cell tolerance by CD72 in a murine model.EndoU is a novel regulator of AICD during peripheral B cell selection.The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.Recent advances in de novo CD5+ diffuse large B cell lymphoma.B lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus.B-cell-mediated strategies to fight chronic allograft rejectionB-1 lymphocytes in mice and nonhuman primates.Perspectives on fetal derived CD5+ B1 B cellsProgrammed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.Multiple regulatory mechanisms control B-1 B cell activation.Peritoneal cavity B-1a cells promote peripheral CD4+ T-cell activation.B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.A Hard(y) Look at B-1 Cell Development and Function.
P2860
Q26865940-85E83AD8-2F26-4015-BD2F-947942472A11Q28216264-D65786DB-5B80-4005-9B2D-6BD5870131E1Q33933105-9E066DE9-AE56-447E-97F8-9D7010A1B31DQ33950129-C974BB7D-7189-40FF-986C-80C20205EEB7Q34299834-3808B67B-2223-4C55-A4DC-5B1260C0E3F5Q35072498-B27292FD-F515-4D5A-9C07-FB75948BFCEBQ35428053-65DFCBD1-9BBA-4643-ABC0-BCF331D3E410Q35840786-2497E492-3088-4912-932D-44148DD0CA6EQ35847513-26319B4E-2A63-4DDA-BEA2-2C3A2444F44FQ35889002-3AB800A8-1EEE-47A3-A816-CD51E29A519FQ36041818-FD96269C-7082-407F-9E28-DAD0B1FEEB06Q36058417-FBD2C89C-44B0-427D-BDF8-6912AA57587BQ36148399-B764793D-F6C7-45AA-B5F7-A56462F819CBQ36228387-BE244784-63F7-4C39-9F7E-D926E23C7A27Q36370429-A6474FD8-9C59-4B8F-8D15-2B99C1B92B19Q36370883-48006F39-6A5B-4C8A-B912-EAC49DBCF117Q36373409-446CC24E-6C52-48AF-A29A-6D736214180CQ36570650-4DB7B995-72F6-4582-9FE2-BCD68DE98942Q36652772-C86E1CDE-DADE-4CB2-8478-2E31ED8D9EE8Q36979261-593FFF0A-9EA7-458E-922B-EC96B361F9B6Q37065111-1E520A7D-4B75-4F50-92EE-FC92556DA4EFQ37083637-4FF184A1-97FA-4FC1-9122-D191A9CE7978Q37083680-57E65CC7-591E-4550-8FD9-9630700B3321Q37307895-497D5179-4711-42A5-B8F9-9EB631D7D981Q37374073-49C4CA6D-1EC3-42FD-B56D-B0117A6885A2Q37405410-F84068F8-F568-4385-ADA4-FD5E49DD271BQ37465464-597665D7-441F-4C90-8DF8-66BCFE04318FQ37483153-800E5B5F-BD4C-49F1-B872-E8D80D208A50Q37863856-F92DF67F-9A25-4B98-86C5-B67E792542E8Q38108555-77764EEA-2E20-430E-A699-C835FCF156ACQ38159695-4384B668-953C-46C4-90CB-4BD5B2840D1DQ38175026-700A494C-51CA-4CA2-ADA4-2B359985ED40Q38452441-CDC9F7C6-D160-4F6D-8D48-81F21999887FQ38580651-554432C1-603E-4AC5-B4A0-500B0540248BQ39034572-C75CEA36-6C5F-4CB6-8807-35F3C4D4F95BQ39319246-959C0E89-B58C-4499-B54E-69B8F7BFD0E0Q41921556-F4EFA89F-450A-487D-9677-700F2AAE1979Q42261106-6B00E97A-6680-4792-B9E4-DB5F9210E382Q42944730-4FCFBBB5-2030-4849-A0D9-07597C715888Q46130357-137600D3-DEA3-40CD-B1B8-F70CAF934722
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
CD5 maintains tolerance in anergic B cells
@ast
CD5 maintains tolerance in anergic B cells
@en
type
label
CD5 maintains tolerance in anergic B cells
@ast
CD5 maintains tolerance in anergic B cells
@en
prefLabel
CD5 maintains tolerance in anergic B cells
@ast
CD5 maintains tolerance in anergic B cells
@en
P2093
P2860
P356
P1476
CD5 maintains tolerance in anergic B cells
@en
P2093
P2860
P304
P356
10.1084/JEM.191.5.883
P407
P577
2000-03-01T00:00:00Z